Moore David

Avg. Two Year Performance

(81%) Avg. Purchase Return
(35%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return10%13%25%(40%)(81%)
Purchase Success Rate2 of 22 of 22 of 21 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 1.5K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

VP, Commercial Operations:

Holdings: 1.05K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--